Circ_0002577/miR-126-5p/MACC1 axis promotes endometrial carcinoma progression by regulation of proliferation, migration, invasion, and apoptosis of endometrial carcinoma cells-Reference-Cited by-同舟云学术

Circ_0002577/miR-126-5p/MACC1 axis promotes endometrial carcinoma progression by regulation of proliferation, migration, invasion, and apoptosis of endometrial carcinoma cells

Published:2022-02-01 Issue:2 Volume:306 Page:481-491
ISSN:1432-0711
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Wang Wenzhi^ORCID,Jin Wen,Liu Xiaoying,Zheng Lei

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-022-06412-8.pdf

Reference31 articles.

1. Sorosky JI (2012) Endometrial cancer. Obstet Gynecol 120(2 Pt 1):383–397

2. Genestie C, Leary A, Devouassoux M et al (2017) Histological and molecular classification of endometrial carcinoma and therapeutical implications. Bull Cancer 104(12):1001–1012

3. Ali AT (2013) Risk factors for endometrial cancer. Ceska Gynekol 78(5):448–459

4. Holland CM (2008) The role of radical surgery in carcinoma of the endometrium. Clin Oncol (R Coll Radiol) 20(6):448–456

5. Memczak S, Jens M, Elefsinioti A et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333–338

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic risk stratification value of MACC1 expression in patients with gastric cancer;Clinical and Translational Oncology;2024-06-13

2. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08

3. Latest advances in the study of non-coding RNA-mediated circadian rhythm disorders causing endometrial cancer;Frontiers in Oncology;2023-11-22

4. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway;Anti-Cancer Drugs;2022-09-14